Mode
Text Size
Log in / Sign up

GWAS identifies 282 insulin resistance loci, links to fat distribution and candidate mediators

GWAS identifies 282 insulin resistance loci, links to fat distribution and candidate mediators
Photo by Sweet Life / Unsplash
Key Takeaway
Interpret genetic insulin resistance associations cautiously; clinical relevance not established.

This genome-wide association study and Mendelian Randomization analysis investigated the genetic architecture of insulin resistance using multi-trait analysis of fasting insulin, triglycerides, and HDL cholesterol. The study included up to 1.25 million individuals, though specific population characteristics were not reported. Researchers examined genetic variants without a direct clinical comparator.

The analysis identified 282 insulin resistance-associated loci, with 70 being novel findings. A polygenic score linked insulin resistance to an adverse fat distribution pattern. The study implicated 72 adipose-specific regulatory loci and found that in vitro knockdown of LAMB1 enhanced adipogenesis. Through Mendelian Randomization, circulating KLK1 was identified as a candidate causal mediator in hyperinsulinemia. No safety or tolerability data were reported as this was a genetic study.

Key limitations include the observational nature of most findings, with only one candidate mediator identified through causal inference methods. Effect sizes, p-values, and confidence intervals were not reported for most outcomes. The study population details, follow-up duration, and funding sources were not specified. While this research advances understanding of insulin resistance genetics, its clinical relevance remains unestablished and requires validation in diverse populations.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Insulin resistance (IR) is a key driver of cardiometabolic disease, yet its genetic and regulatory architecture remains incompletely understood. We performed a multi-trait GWAS of fasting insulin, triglycerides, and HDL cholesterol (n [≤] 1.25 million), identifying 282 IR-associated loci, including 70 novel. Polygenic score analyses linked IR to an adverse fat distribution characterized by reduced subcutaneous and increased visceral and ectopic fat. Stratifying loci by BMI associations revealed biologically distinct variant subgroups with divergent regulatory activity during adipogenesis. Enhancer-to-gene mapping implicated 72 loci in adipose-specific regulation, including a novel LAMB1 locus, wherein knockdown enhanced adipogenesis in vitro. Coding variants in PLAUR and INPP5A implicated inflammatory and calcium signaling pathways, while Mendelian Randomization identified circulating KLK1 as a candidate causal mediator in hyperinsulinemia. Our findings refine the genetic landscape of IR, highlight adipose dysfunction as a central mechanism, and nominate new targets for mechanistic and therapeutic investigation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.